Last reviewed · How we verify
Verorab®
Verorab is a recombinant rabies vaccine.
Verorab is a recombinant rabies vaccine. Used for Pre-exposure prophylaxis and post-exposure prophylaxis against rabies.
At a glance
| Generic name | Verorab® |
|---|---|
| Sponsor | Sinovac Biotech Co., Ltd |
| Drug class | vaccine |
| Modality | Biologic |
| Therapeutic area | Infectious disease |
| Phase | Phase 3 |
Mechanism of action
It works by stimulating the body's immune system to produce antibodies against the rabies virus, providing protection against the disease.
Approved indications
- Pre-exposure prophylaxis and post-exposure prophylaxis against rabies
Common side effects
- Pain, redness, swelling, or itching at the injection site
Key clinical trials
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults (PHASE3)
- A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate (PHASE1)
- Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso (PHASE1)
- Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland (PHASE3)
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults (PHASE3)
- Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen (PHASE3)
- Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell) (PHASE2)
- Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Verorab® CI brief — competitive landscape report
- Verorab® updates RSS · CI watch RSS
- Sinovac Biotech Co., Ltd portfolio CI